UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.15 -2.78 (-3.39%) GOLD FUTURES
2,329.10 +26.20 (+1.14%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,743.36 -2,245.96 (-4.68%)
NovaBay Pharmaceuticals, Inc. (NBY)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.91M |
| Enterprise value | 4.47M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.02 |
| Price/book (mrq) | 2.14 |
| Enterprise value/revenue | 0.30 |
| Enterprise value/EBITDA | -0.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.01 |
| 52-week change 3 | -92.23% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 1.2800 |
| 52-week low 3 | 0.0700 |
| 50-day moving average 3 | 0.1168 |
| 200-day moving average 3 | 0.3253 |
Share statistics
| Avg vol (3-month) 3 | 2.39M |
| Avg vol (10-day) 3 | 3.05M |
| Shares outstanding 5 | 36.06M |
| Implied shares outstanding 6 | 36.06M |
| Float 8 | 29.96M |
| % held by insiders 1 | 0.03% |
| % held by institutions 1 | 3.30% |
| Shares short (15 Apr 2024) 4 | 208.11k |
| Short ratio (15 Apr 2024) 4 | 0.09 |
| Short % of float (15 Apr 2024) 4 | 0.58% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.58% |
| Shares short (prior month 15 Mar 2024) 4 | 116.07k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:35 |
| Last split date 3 | 16 Nov 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -65.46% |
| Operating margin (ttm) | -21.41% |
Management effectiveness
| Return on assets (ttm) | -24.59% |
| Return on equity (ttm) | -139.02% |
Income statement
| Revenue (ttm) | 14.73M |
| Revenue per share (ttm) | 3.49 |
| Quarterly revenue growth (yoy) | 2.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -4.8M |
| Net income avi to common (ttm) | -16.7M |
| Diluted EPS (ttm) | -3.9600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.13M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 2.74M |
| Total debt/equity (mrq) | 82.68% |
| Current ratio (mrq) | 1.67 |
| Book value per share (mrq) | 0.12 |
Cash flow statement
| Operating cash flow (ttm) | -4.13M |
| Levered free cash flow (ttm) | -173.88k |
© 2024 Yahoo. All rights reserved.